Talking about what others are afraid to say
GLP-1 drugs like Ozempic®, Wegovy®, Zepbound®, and Mounjaro® are revolutionizing the treatment of obesity. Study results showing typical weight loss between 15% and over 20% have generated unprecedented excitement among …
The GLP-1 Revolution Has a Retention Problem: What Social Media Is Revealing About the Hidden Challenge Read More
For years, pharma companies assumed that if they built a product website, patients would come. Many did. But they didn’t stay. Today, online health seekers are spending less time on …
Why Patients Trust Social Health Sources More Than Pharma Websites Read More
If a healthcare system’s playbook is still just “treatment,” it’s going to get left behind. The old model of diagnose, treat, bill, repeat just doesn’t work anymore. It’s breaking down …
Why People aren’t just “patients” anymore; they’re consumers. Read More
For decades, pharma has liked its patient feedback one way: tidy. In advisory boards, clinical trials, and scripted customer service calls, the feedback is structured, logged, and controlled. Then there’s …
Should Pharma Marketers Monitor Social Media for Side Effects—Or Just Ignore It? Read More